Skip to main content
. 2014 Jun 3;8(2):566–574. doi: 10.3892/ol.2014.2214

Figure 4.

Figure 4

HCA is significantly increased in the sera of the patients with OVC. (A) Mass peak pattern of a low-mass ion with 184.05 m/z on mass spectra. (B) Increase in HCA in patients with OVC compared with the control participants. HCA was not detected in the majority of the control participants. HCA was found to be significantly increased in the sera of the patients with OVC (P<0.001). HCA, L-homocysteic acid; OVC, ovarian cancer; MS, mass spectrometry.